| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/01/2007 | WO2007023628A1 Secretory antigen 1 protein of babesia gibsoni, dna encoding the same and use thereof |
| 03/01/2007 | WO2007023184A1 System for screening cells for high expression of a protein of interest (poi) |
| 03/01/2007 | WO2006072845A3 Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070048828 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048311 ANTI-INTERFERON-alpha ANTIBODIES |
| 03/01/2007 | US20070048301 Compositions and methods for the treatment of immune related diseases |
| 03/01/2007 | US20070048218 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | CA2618203A1 System for screening cells for high expression of a protein of interest (poi) |
| 02/28/2007 | EP1757941A1 Method for immunochemically assaying anti-hm1.24 antibody |
| 02/28/2007 | EP1757701A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth |
| 02/28/2007 | EP1757311A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1756158A1 Method for activating of t cell protein tyrosine phosphatase and therapeutical methods based thereon |
| 02/28/2007 | EP1755658A2 Human complement c3 derivates with cobra venom factor-like function |
| 02/28/2007 | EP1755640A1 Hybrid recombinases for genome manipulation |
| 02/28/2007 | EP1436002B1 Use of peptide vectors to improve the immune response to antigens |
| 02/28/2007 | EP1346041B1 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 02/28/2007 | EP1240317B1 Nucleic acid vaccination |
| 02/28/2007 | EP0888122B1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 02/28/2007 | CN1922204A Il-4/il-13 sepecific polypeptides and therapeutic uses thereof |
| 02/28/2007 | CN1921889A Targeted immunogens |
| 02/28/2007 | CN1920021A Preparation method of activated insulin-like growth factor-II mediated by insulin-like growth factor binding protein-6 |
| 02/28/2007 | CN1920015A Recombination tyrosine kinase expressed in pichia yeast organelle, gene, derivative fusion albumen and preparation method thereof |
| 02/28/2007 | CN1919874A Antibody molecule ATF-Fc fusion albumen of antiurokinase type fibrinolysin activator receptor and use thereof |
| 02/28/2007 | CN1919873A Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof |
| 02/28/2007 | CN1919872A Fusion albumen containing HSP70 ATPase structure field and antigen peptide and application thereof |
| 02/28/2007 | CN1302103C CD 19XCD3 specific polypeptides and uses thereof |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183401 Tumor suppressor protein (designated NOEY2) expressed in normal ovarian and breast surface epithelial cells but absent or down-regulated in ovarian and breast cancer cells; vectors, host cells, detection kits |
| 02/27/2007 | US7183399 Nucleotide sequences coding reef coral fluorescent proteins for use as diagnostic tool in genetic engineering |
| 02/27/2007 | US7183397 NK-2 homeobox transcription factor |
| 02/27/2007 | US7183393 Fusion protein of a polypeptide and a heparan sulphate glycosaminoglycan chain which influences binding affinity, binding specificity, and stability; polypeptide of fusion protein can be a cell growth factor, pathogen-related antigen, nuclear protein, cell adhesion molecules, enzyme or enzyme inhibitor |
| 02/27/2007 | US7183382 Mammalian genes; related reagents and methods |
| 02/22/2007 | WO2007020402A1 Insulin-like growth factor ii (igf-ii) binding factors |
| 02/22/2007 | WO2007020243A2 Vaccine based on virus-neutralizing antibodies |
| 02/22/2007 | WO2006135385A3 Antagonizing interleukin-21 receptor activity |
| 02/22/2007 | WO2006134190A3 Agents and methods based on the use of the eda domain of fibronectin |
| 02/22/2007 | WO2006103472A3 Soluble vox2 protein as immunoregulatory factor |
| 02/22/2007 | WO2006071441A3 Antibodies directed to gpnmb and uses thereof |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042945 Nouvelles compositions et methods de traitement du psoriasis |
| 02/22/2007 | US20070042485 Modified TRAP protein for producing nano-scale electrical devices, and a method for producing such a protein |
| 02/22/2007 | US20070042442 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041969 Apo-2DcR |
| 02/22/2007 | US20070041967 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 02/22/2007 | US20070041964 WISP polypeptides and nucleic acids encoding same |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | CA2619048A1 Vegf-activated fas ligands |
| 02/21/2007 | EP1754787A2 Methods for producing members of specific binding pairs |
| 02/21/2007 | EP1754715A1 Vaccine on the basis of virus-neutralising antibodies |
| 02/21/2007 | EP1754485A1 Remedy for neurodegenerative diseases |
| 02/21/2007 | EP1608685B1 Vegf antagonists for the treatment of diabetes |
| 02/21/2007 | EP1517913B1 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
| 02/21/2007 | EP1212422B1 Human ctla-4 antibodies and their uses |
| 02/21/2007 | EP1137812B1 Dna-protein fusions and uses thereof |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1916173A Method for preparing human pancreatic glucagons like polypeptide ¿C 1, and fusion proten of human serum albumin, and products |
| 02/21/2007 | CN1916172A Method for preparing parathormone 1-34 |
| 02/21/2007 | CN1916017A Process for producing hydrophobic polypeptides, proteins or peptides. |
| 02/21/2007 | CN1915425A Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/21/2007 | CN1301268C Thrombus-resolving and anticoagulation double function fusion protein and use thereof |
| 02/20/2007 | US7179470 Hepatitis-C virus testing |
| 02/20/2007 | US7179467 DCMP2 polypeptide |
| 02/15/2007 | WO2007018475A1 Novel anticoagulant polypeptides and complex |
| 02/15/2007 | WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus |
| 02/15/2007 | WO2006129828A3 Target substance capturing molecule |
| 02/15/2007 | WO2006078567A3 Vaccines and mucosal targeting ligands to facilitate vaccine delivery |
| 02/15/2007 | US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036783 Antibody complexes |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036752 IL-2 fusion proteins with modulated selectivity |
| 02/15/2007 | CA2618554A1 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 02/15/2007 | CA2616069A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 02/14/2007 | EP1752544A1 Probe for detecting nuclear receptor agonist or antagonist and method of screening agonist or antagonist to nuclear receptor with the use of the same |
| 02/14/2007 | EP1752472A2 Chimeric amyloid beta peptides |
| 02/14/2007 | EP1752471A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 02/14/2007 | EP1750759A2 Screening method using antibody heavy chains |
| 02/14/2007 | EP1670813A4 Rho antibody and tag to purify cell surface proteins |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1206495B1 Chimeric polypeptides, method for production and uses thereof |
| 02/14/2007 | EP1200577B1 In vitro selection and optional identification of polypeptides using solid support carriers |
| 02/14/2007 | EP1200458B1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1911962A Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 02/14/2007 | CN1911958A Polypeptide for inhibiting p38 kinase activity and its application |
| 02/14/2007 | CN1300320C Alzhimer's disease secretase |
| 02/13/2007 | US7176287 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins |
| 02/13/2007 | US7176285 Ligands for human protein histidine phosphatase (PHP1); identifying agonists and antagonists and treating conditions associated with PHPIP-120 imbalance with the identified compounds; cardiovascular disorders; autism; schizophrenia; antiarthritic and -carcinogenic agents; Bardet-Beidl Syndrome; anemia |
| 02/13/2007 | US7176187 Fusion proteins based upon somatostatin receptors |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7175983 Adapter-directed display systems |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |